Today's Date: June 12, 2024
Patriot Motors of Sturgeon Bay Partners with Mothers Against Drunk Driving During June   •   Statement by the Minister of Labour on World Day Against Child Labour   •   Minister Sudds provides an update on Canada's progress on the 2030 Agenda for Sustainable Development   •   Statement by the Minister of Labour on World Day Against Child Labour   •   Parents as Teachers Receives $1.04 Million Grant from Bezos Family Foundation to Advance Life-Saving Maternal Health Initiative   •   PCI to Open State-of-the-Art Presort Mailing Facility in Indianapolis, Generating Nearly 100 Jobs   •   Grayce Raises $10.4M Series A for Family Care Solution, Scaling Social Care Management Platform of Digital Tools and Social Work   •   The Benefits Are On The Balance Sheet: Corporate America Must Stand By DEI And Chief Diversity Officers   •   Global Brain and Vision Research Nonprofit to Host Inaugural Concert for Cures Celebrating Science   •   CCM Latino Mortgage Originators Ranked #1 in Northeast and Southwest Regions   •   Inherited genetic factors may predict the pattern of X chromosome loss in older women   •   The Best of The Southwest Luxury Lifestyle Magazine Debuts   •   “Golden Eight” Collection of Signed Michael Phelps Paintings Unveiled for the First Time Ahead of 2024 Summer Olympi   •   76-Year-Old Woman Walking 754 Miles from Chicago to Montgomery for Justice   •   Skyway Capital Markets, LLC Advises on the Sale of Aqua ChemPacs, LLC   •   Hong Kong Tourism Board and Art Basel Announce Three-Year Global Partnership   •   SBS Entertainment, La Musica and Mega 96.3FM's Summer Spotlight Series is back for its second year featuring live music performa   •   Canada celebrates its top educators for the 30th year, honouring them with the Prime Minister's Awards   •   The American Warrior Association Receives City of Fort Worth Proclamation Marking June 11 as Moral Injury Awareness Day   •   Matthew Carnes, S.J., Named Vice President for Mission and Ministry at Santa Clara University
Bookmark and Share

Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities thr

Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism

PR Newswire

DUBLIN, May 22, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a strategic collaboration with Life Science Cares to drive social impact through employee volunteerism in the United States. This partnership reinforces Jazz's commitment to supporting the communities in which employees work and live. Life Science Cares is a collective effort to activate the financial and human capital of the life sciences industry across several regions in the U.S. – and partner with nonprofits – to disrupt the cycle of poverty and inequality in those communities. With hubs around Jazz's U.S. offices in Palo Alto, Philadelphia and San Diego, Life Science Cares will help enable Jazz's goals to harness the passion of its employees to make a meaningful difference in their communities.

Tom Croce, vice president, global patient engagement, advocacy & social impact at Jazz Pharmaceuticals said, "We are proud of the work we are doing through direct philanthropy, employee volunteerism and with partners like Life Science Cares, to strengthen community organizations and provide critical support to those in need and seeking opportunity. This new collaboration provides us the opportunity to take impactful actions to address inequities in our communities and develop meaningful relationships with nonprofit organizations across the United States."

With a goal to increase employee volunteerism in our communities, Jazz's employee volunteer program empowers employees to drive outreach and give back to their local communities. Jazz offers a Global Volunteer Day Policy enabling employees to dedicate one paid workday each calendar year to volunteer at the non-profit organization of their choice.

Life Science Cares prides itself on not only being a grant-making organization, but one that actively seeks to partner with its grantees and help solve societal problems through a combination of volunteerism and thought partnership from life science industry staff.

Sarah MacDonald, CEO of Life Science Cares says, "We are thrilled to partner with Jazz to activate their employees in service of our mission to disrupt the cycle of poverty and inequality in the communities in which we live and work. Together, we can do more." 

The U.S. has the highest overall poverty rate among developed nations. Thirty-four million people in the U.S. are food insecure and 1 in 500 Americans is unhoused. Life Science Cares was founded in 2016 by life science leaders committed to harnessing the industry's resources to address these problems. Today, the organization operates in Boston, Philadelphia, New York, San Diego and the San Francisco Bay Area and has invested more than $16 million and 55,000 volunteer hours in partnership with community organizations. 

MacDonald adds, "Overcoming socio-economic inequities is a complex challenge and requires addressing gaps in access to basic needs, education, and economic opportunity. We believe the life science industry— full of creative, collaborative and innovative people—is uniquely positioned to make a meaningful difference."

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit for more information.

About Life Science Cares

Life Science Cares (LSC) activates the financial and human capital of the life science industry and partners with nonprofits to disrupt the cycle of poverty and inequality in our communities. The organization helps solve societal problems through active caring, combining grants with supportive services such as volunteerism, thought leadership, and scientific expertise.  Now operating in five life science hubs (Boston, Philadelphia, San Diego, the San Francisco Bay Area and New York), LSC has invested more than $16M and tens of thousands of volunteer hours in community organizations providing access to basic needs, access to education or access to opportunity.


Jazz Media Contact:

Kristin Bhavnani

Head of Global Strategic Brand Engagement

Jazz Pharmaceuticals plc

Ireland +353 1 637 2141

U.S. +1 215 867 4948

Jazz Investor Contact:

Andrea N. Flynn, Ph.D.

Vice President, Head, Investor Relations

Jazz Pharmaceuticals plc

Ireland +353 1 634 3211

U.S. +1 650 496 2717

Life Science Cares Contact:

Brandi Burgess

Director of Development

Life Science Cares Philadelphia

+1 205 915 2466

Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)


Cision View original content to download multimedia:

SOURCE Jazz Pharmaceuticals plc

Back to top
| Back to home page

White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News